REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
65,04 R$
0,00%
(0,00) 1D
14 ოქტ, 16:56:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN34...
Open
64,20 R$
High
65,04 R$
Low
64,20 R$
Mkt. cap
80,14 მლრდ.
Avg. vol.
781,00
Volume
136,00
52-wk high
73,13 R$
52-wk low
49,91 R$
Shares outstanding
101,14 მლნ.
No. of employees
15 ათ.
Open
64,20 R$
High
65,04 R$
Low
64,20 R$
Mkt. cap
80,14 მლრდ.
Avg. vol.
781,00
Volume
136,00
52-wk high
73,13 R$
52-wk low
49,91 R$
Shares outstanding
101,14 მლნ.
No. of employees
15 ათ.
News stories
From web sources and news partners
Trefis
·
6 საათის წინ
What Could Send Regeneron Stock Higher?
Seeking Alpha
·
7 საათის წინ
Regeneron a new Buy at UBS as Street undervalues Dupixent's future
Kalkine Media
·
7 საათის წინ
Regeneron Pharmaceuticals (NASDAQ:REGN): What Changes After Its Latest Company Update?
Investing.com Canada
·
8 საათის წინ
Form 144 REGENERON PHARMACEUTICALS For: 14 October By Investing.com
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc BDR
CEOლეონარდ შლაიფერი
Employees15,3 ათ.
Founded1988
HeadquartersTarrytown, ნიუ-იორკის შტატი, ამერიკის შეერთებული შტატები
Sector-
Websiteregeneron.com